Delaney Dennis R Buys 710 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Delaney Dennis R lifted its position in UnitedHealth Group Incorporated (NYSE:UNH) by 8.5% during the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 9,096 shares of the healthcare conglomerate’s stock after buying an additional 710 shares during the period. UnitedHealth Group comprises 2.5% of Delaney Dennis R’s portfolio, making the stock its 21st largest holding. Delaney Dennis R’s holdings in UnitedHealth Group were worth $4,632,000 at the end of the most recent reporting period.

Other hedge funds also recently added to or reduced their stakes in the company. Macroview Investment Management LLC boosted its holdings in UnitedHealth Group by 671.4% in the second quarter. Macroview Investment Management LLC now owns 54 shares of the healthcare conglomerate’s stock worth $28,000 after purchasing an additional 47 shares during the last quarter. Delos Wealth Advisors LLC raised its position in shares of UnitedHealth Group by 757.1% during the 1st quarter. Delos Wealth Advisors LLC now owns 60 shares of the healthcare conglomerate’s stock valued at $30,000 after purchasing an additional 53 shares during the period. True Wealth Design LLC purchased a new position in UnitedHealth Group in the 4th quarter worth approximately $31,000. Bbjs Financial Advisors LLC bought a new stake in shares of UnitedHealth Group during the second quarter valued at approximately $31,000. Finally, Signature Resources Capital Management LLC boosted its position in shares of UnitedHealth Group by 40.0% during the second quarter. Signature Resources Capital Management LLC now owns 63 shares of the healthcare conglomerate’s stock worth $32,000 after acquiring an additional 18 shares during the last quarter. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity at UnitedHealth Group

In other news, CAO Thomas E. Roos sold 2,851 shares of the company’s stock in a transaction on Wednesday, July 17th. The shares were sold at an average price of $569.88, for a total transaction of $1,624,727.88. Following the completion of the sale, the chief accounting officer now owns 29,501 shares of the company’s stock, valued at $16,812,029.88. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. In related news, EVP Erin Mcsweeney sold 1,500 shares of the stock in a transaction that occurred on Thursday, July 18th. The stock was sold at an average price of $579.03, for a total value of $868,545.00. Following the completion of the sale, the executive vice president now owns 7,785 shares of the company’s stock, valued at $4,507,748.55. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, CAO Thomas E. Roos sold 2,851 shares of the company’s stock in a transaction on Wednesday, July 17th. The shares were sold at an average price of $569.88, for a total value of $1,624,727.88. Following the completion of the sale, the chief accounting officer now owns 29,501 shares of the company’s stock, valued at $16,812,029.88. The disclosure for this sale can be found here. 0.33% of the stock is owned by corporate insiders.

UnitedHealth Group Stock Performance

Shares of NYSE:UNH opened at $580.32 on Thursday. The company has a market capitalization of $535.88 billion, a price-to-earnings ratio of 35.47, a price-to-earnings-growth ratio of 1.64 and a beta of 0.58. The company has a quick ratio of 0.88, a current ratio of 0.88 and a debt-to-equity ratio of 0.67. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $607.94. The firm has a 50 day moving average of $574.38 and a 200 day moving average of $519.42.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, July 16th. The healthcare conglomerate reported $6.80 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $6.66 by $0.14. The firm had revenue of $98.86 billion for the quarter, compared to the consensus estimate of $98.73 billion. UnitedHealth Group had a net margin of 3.66% and a return on equity of 26.55%. The company’s quarterly revenue was up 6.4% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $6.14 EPS. On average, sell-side analysts predict that UnitedHealth Group Incorporated will post 27.69 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th will be given a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.45%. The ex-dividend date is Monday, September 16th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 51.34%.

Wall Street Analysts Forecast Growth

UNH has been the topic of several recent research reports. Robert W. Baird upped their target price on shares of UnitedHealth Group from $597.00 to $640.00 and gave the company an “outperform” rating in a research report on Wednesday, July 17th. Truist Financial upped their price objective on UnitedHealth Group from $600.00 to $640.00 and gave the company a “buy” rating in a research report on Wednesday, July 17th. Cantor Fitzgerald reissued an “overweight” rating and set a $591.00 target price on shares of UnitedHealth Group in a research report on Monday. Jefferies Financial Group raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and lifted their price objective for the stock from $481.00 to $647.00 in a research note on Wednesday, July 17th. Finally, HSBC increased their target price on shares of UnitedHealth Group from $580.00 to $610.00 in a research note on Thursday, July 18th. One analyst has rated the stock with a hold rating, nineteen have given a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Buy” and a consensus price target of $614.17.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.